Onconic Therapeutics

Onconic Therapeutics Share · KR7476060009 (XKOS) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Onconic Therapeutics
No Price
Closing Price XKOS 30.04.2026: 21.250,00 KRW
30.04.2026 06:30
Current Prices from Onconic Therapeutics
ExchangeTickerCurrencyLast TradePriceDaily Change
XKOS: KOSDAQ
KOSDAQ
476060.KQ
KRW
30.04.2026 06:30
21.250,00 KRW
-
Share Float & Liquidity
Free Float 49,66 %
Shares Float 5,5 M
Shares Outstanding 11,07 M
Company Profile for Onconic Therapeutics Share
Onconic Therapeutics, Inc. is a biopharmaceutical company. It engages in the research and development of new drugs in the field of acid-related diseases and anti cancer. The company was founded on May 7, 2020 and is headquartered in Seoul, South Korea.

Company Data

Name Onconic Therapeutics
Company Onconic Therapeutics
Website http://www.onconic.co.kr
Primary Exchange XKOS KOSDAQ
ISIN KR7476060009
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO John Kim
Market Capitalization 235 Mrd.
Country South Korea
Currency KRW
Employees 0,1 T
Address 11th Floor, Star Building, 12 Teheran-ro 26-gil, Gangnam-gu, 06236 Seoul
IPO Date 2024-12-19

Stock Splits

Date Split
10.10.2025 4:1

Ticker Symbols

Name Symbol
KOSDAQ 476060.KQ
More Shares
Investors who hold Onconic Therapeutics also have the following shares in their portfolio:
Global X U.S. 500 Income Edge ETF
Global X U.S. 500 Income Edge ETF ETF
LB.HESS.THR.CA.TIL.07D/19
LB.HESS.THR.CA.TIL.07D/19 Bond